Contact | Print version | PDF version | Send article | RSS feed

Lorus Therapeutics announces the appointment of a new President and Chief Executive Officer

21 Sep 2006 - The board of directors of Lorus Therapeutics Inc. announced that Dr. Aiping H. Young will take the position of President and Chief Executive Officer of Lorus on September 21, 2006, the occasion of the Company's Annual General Meeting.
 
Dr. Young has served at various times as Lorus' Vice-President of Research and Development, Chief Technology Officer, and Chief Operating Officer. Previously, Dr. Young was Vice-President of Research for GeneSense Technologies, a biotechnology company that she co-founded, and was a member of its board of directors. Dr. Young has played a key role in the overall development of Lorus and has participated in all phases of Lorus' drug development program and business activities.